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One hundred adult female patients scheduled for outpatient laparoscopic procedures were studied. Each 
patient received intravenous premedication about 30 min before induction of anaesthesia. The premedications 
were given in a double-blind random order and were either a placebo, morphine (0.04 mg/kg), meperidine 
(0.35 mg/kg), fentanyl (0.75 pg/kg) or sufentanil (0.15 pg/kg). All patients received a standard anaesthetic 
regimen. Transient light-headedness was common following narcotic injections. Overall, sufentanil was 
superior to the placebo and to other narcotics in its ability to reduce preoperative anxiety and to provide 
more satisfactory induction, maintenance and recovery from anaesthesia. The incidence of postoperative 
nausea, vomiting and other side effects was not higher and discharge times were not longer after sufentanil 
compared to the placebo group. Complete recovery as assessed by telephone interview 24-48 h after the 
operation revealed no difference between the sufentanil and the other groups. The results of this study 
indicate that intravenous short-acting narcotics like fentanyl or sufentanil should be considered as an 
alternative premedicant for anxious patients who are scheduled for outpatient surgery. 
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The use of preanaesthetic medication is still a matter of 
much controversy in outpatient anaesthesia practice. 
Ambulatory surgical patients have little prior contact 
with their anaesthesiologist, have little time to get 
adjusted to the hospital environment and are thus 
often very anxious when they arrive in the preopera- 
tive room. Some of these patients might benefit from 
being given a pharmacological premedication in ad- 
dition to psychological support. 
It is not uncommon for anaesthesiologists to admin- 
ister a small dose of short-acting narcotic during in- 
duction of anaesthesia as a part of the overall anaes- 
thesia care plan. The narcotic is expected to reduce 
the minimum alveolar concentration (MAC) and thus 
reduce the need for inhalation anaesthetic agents. In 
addition, the analgesic effect of the intraoperative nar- 
cotic may extend to the immediate postoperative per- 
iod to provide smoother recovery. We wondered if it 
would be more beneficial for the patient if we adminis- 
tered the same small dose of a short-acting narcotic as 
an intravenous premedication instead of using it dur- 
ing the induction of anaesthesia. Because of the report- 
ed “euphoric” effect of some of the narcotics, these 
premedicants might reduce patients’ preoperative 
anxiety, in addition to providing smoother induction, 
maintenance and recovery from anaesthesia. 
The aim of the study was to compare comparable 
doses of morphine, meperidine, fentanyl and sufentanil 
with a placebo (normal saline) given intravenously 
as preanaesthetic medication for ambulatory surgical 
patients. We assessed the effects of the premedicants 
on anxiety, sedation, ease of anaesthetic induction, 
maintenance, requirement for postoperative anal- 
gesics, recovery time and frequency of side effects. 
PATIENTS AND METHODS 
Prior approval from the Institutional Ethical Committee concerning 
use of human subjects for research was obtained. Each patient gave 
written informed consent before participating in the study. 
The study included 100 adult female patients (ASA I or 11) 
between the ages of 18 and 45 years who were scheduled for an 
outpatient laparoscopic procedure (diagnostic or for tuba1 ligation) 
under general anaesthesia. Drug-dependent individuals, patients who 
had received drugs that affect the central nervous system within the 
last 7 days and patients with significant involvement of cardiac, 
respiratory, metabolic or central nervous systems were excluded. 
The assigned anaesthesiologist performed the routine preanaesthetic 
evaluation in the preoperative waiting room. One of the investigators 
then approached the patient and obtained informed consent for the 
study. 
After the baseline assessment (see below), approximately 30 min 
prior to the induction of anaesthesia, one of the four active medi- 
cations or a placebo was injected through a previously secured intra- 
venous route. The doses of premedicants used were morphine, 0.04 
mg. kg-’, meperidine 0.35 mg. kg-I, fentanyl 0.75 pg. kg-‘, sufen- 
tanilO.15 pg . kg-’ and placebo (normal saline) 2 ml. There were 20 
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cases in each group, All medications were calculated and dispensed 
in equal volume (2  ml) by the same nurse throughout the study. 
This nurse was not involved in any of the subsequent assessments. 
Anxiety was assessed subjectively, utilizing a visual analogue scale, 
which consisted of a 100-mm vertical line, where ‘0’ was marked as 
“no anxiety a t  all” and 100 was marked as “extreme anxiety”. After 
receiving a full explanation of the scale before the premedication, 
patients were asked to place a mark on the scale to denote the level 
of current anxiety. Each patient assessed her own anxiety before 
premedication, 15 min after premedication, and again just before 
induction of anaesthesia in the operating room. 
Arterial pressure (systolic, diastolic and mean) and pulse rates 
were recorded before premedication and at 15-min intervals there- 
after until the time of induction by means of an automatic noninva- 
sive device with a printer. Respiratory rates were also recorded. 
Vital signs continued to be recorded by the automatic device during 
induction of anaesthesia (every minute), maintenance period (every 
3-5 min) and in the recovery room (every 15 min). Each patient 
was closely observed following the premedication, and the frequency 
of side affects such as pain on injection, dizziness, nausea and sleepi- 
ness immediately after premedication were noted following direct 
questioning. Grades of sedation were noted before premedication, 15 
min later and just before induction of anaesthesia utilizing a scoring 
system (1) in which 1 =no sedation, 2 = relaxed but not sleepy, 3 = 
sleepy and easily arousable by a light touch or gentle command, 4 =  
asleep and arousable by a strong stimulus, and 5 =patient unable to 
communicate. 
The assigned anaesthesiologist (not part of the study and blind to 
the premedication given) gave overall evaluation of the effectiveness 
of the premedicant as excellent, good, fair, or poor just prior to the 
induction of anaesthesia using sleepiness, anxiety and overall calm- 
ness as the criteria. Anaesthetic technique was standardized in all 
cases. After preoxygenation, induction of anaesthesia was achieved 
with thiamylal, 4 mg . kg-I and vecuronium, 0.1 mg . kg-’. Following 
positive pressure ventilation via a face mask with oxygen and isoflu- 
rane (2%) for 4 min (or until full paralysis was demonstrated by a 
peripheral nerve stimulator), the trachea was intubated. Anaesthesia 
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Fig. 1. Showing distribution of cases with various grades of sedation 
from the five groups. Grade 1 = no sedation, Grade 2 =relaxed but 
not asleep, Grade 3=sleepy and easily arousable. (There were no 
cases in Grade 4 or 5). ANOVA and multiple comparison with 
Scheffe allowances showed, at 15 rnin placebo P<O.OOI against all 
other groups, but just prior to induction placebo P< 0.01 only against 
fentanyl and sufentanil. 
Table 1 
Demography and duration of anesthesia (mean ? s.d.). 
Premedicant n (years) (kg) (em) (min) 
Age Weight Height Duration 
Morphine 20 30.1 k 6.2 61.2 k 8.3 64.1 k 2.3 53.7 & 18.7 
Meperidine 20 30.9 t 4.5 65.3 k 16.5 64.9 2.7 51.5 i 16.3 
Fentanyl 20 29.9 6.6 63.7 & 10.6 64.9k 3.2 54.0 k 19.7 
Sufentanil 20 29.0k3.9 63.4k9.3 64.7k2.1 52.0k8.3 
Placebo 20 30.0k4.9 61.1k10.2 64.2i2.2 48.8+ 11.9 
No significant differences among the groups (ANOVA). 
was maintained with nitrous oxide and oxygen ( 4 2  limin), and 
isoflurane (usually 1 yo). Ventilation was controlled mechanically 
and additional vecuronium (2 mg increments) was administered if 
needed. No additional narcotic was administered unless excessive 
tachycardia (heart beat 100 bpm for 5 min) and/or hypertension 
(systolic pressure more than 150 mmHg (20.0 kPa) for 5 min) were 
present. In that case, fentanyl in 25 pg increments was injected. A 
standard dose of droperidol (0.625 mg) was administered intra- 
venously in all cases just after tracheal intubation as a prophylactic 
antiemetic agent. An orogastric tube (Salem sump) was placed in 
each patient soon after tracheal intubation to decompress the stom- 
ach. The stomach tube was left in place until just before tracheal 
extubation. At the end ofthe procedure, the effect ofvecuronium was 
reversed with appropriate doses of neostigmine and glycopyrrolate. 
In  the recovery room, we rated the recovery score (Aldrete Score, 
0-10) on arrival, arterial pressure, heart rate, and respiratory rate 
every 15 min, the time to complete orientation (day, date and date 
of birth), the time to ambulation and time to discharge. Patients 
were discharged from the recovery room following strict clinical 
criteria (Wetchler criteria) (2). These criteria consisted of stable vital 
signs, absence of respiratory distress, presence of gag and cough 
reflex, ability to walk to the bathroom, ability to void and tolerance 
to oral fluid intake. The frequency of side effects during recovery 
was recorded every 15 min. Any incidence of nausea and vomiting, 
excessive pain (moderate or severe, defined as requiring intravenous 
pain medication), dizziness, headache or other symptoms were re- 
corded after direct questioning. In  cases of excessive nausea or vomit- 
ing (on nurse’s judgment) perchlorperazine 5 mg i.v. was given; in 
case of moderate to severe pain, fentanyl (25 pg i.v.) was adminis- 
tered. The dose was repeated once if necessary. Oral pain medication 
(acetaminophen or ibuprofen) was given when the patients with pain 
could tolerate oral intake. Grades of sedation were also noted every 
15 min, following the same scale used in the preoperative period. 
Grades 4 and 5 were considered excessive drowsiness. 
Table 2 
Side effects following i.v. premedication (%). 
Discomfort 
Premedicant n at i.v. site Drowsy Lightheaded 
Morphine 20 60 t 20 50’ 
Fentanyl 20 20 25 60* 
Sufentanil 20 10 30 50* 
Placebo 20 15 0 5 
t Morphine significantly different from fentanyl, sufentanil and pla- 
cebo, but not from meperidine (chi-square test). 
* Placebo significantly different from all other groups (chi-square 
test). 
Meperidine 20 32 21 53* 
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Statistical analysis 
We used a two-factor ANOVA (profile analysis) for repeated meas- 
ures to compare means within and between groups. Where we found 
interaction in time and group effects, we also used pair-wise t-tests, 
with Bonferroni correction, to test for significance within the groups 
and one-factor ANOVA to compare means between groups at given 
times. This allowed us to test for interactions between time and 
group effects as well as testing for each effect individually. Results 
were considered significant if the P-value was 0.05 or less. 
RESULTS 
Demographic parameters of age, weight, height, and 
duration of anaesthesia (approximately 60 min) were 
comparable in the five groups, and there were no 
significant statistical differences (ANOVA) (Table 1) .  
Approximately 50% of the patients complained of 
transient light-headedness after narcotic premedi- 
cation and 10 to 30% felt drowsy, but these symptoms 
did not last long and both symptoms were clinically 
unimportant. However, in statistical term, the placebo 
group had significantly less light-headedness than all 
other groups. Both morphine and meperidine caused 
a higher incidence of discomfort (usually mild itchiness 
and burning) at the injection site (60% and 32%, 
respectively) compared to the placebo ( 15yo), fentanyl 
(20%) and sufentanil (10%) (Table 2). Regarding 
local discomfort, the morphine group was statistically 
different from the fentanyl, sufentanil and placebo 
groups but not from the meperidine group. No clin- 
ically significant respiratory depression, hypotension, 
tachycardia, bradycardia or chest rigidity were noted 
following any premedication. 
Analyzing the anxiety measure with the two-factor 
ANOVA, we found there to be a significant interaction 
between time and group effects. Therefore we proceed- 
ed to assess the effects individually using a pairwise t- 
test with the Bonferroni correction to compare the 
mean anxiety levels within each drug group between 
the three time points, and then using a one-factor 
ANOVA we compared the mean anxiety levels at  each 
time point between drug groups. Our findings are 
displayed in Table 3. 
Within all groups, except placebo, there was a sig- 
nificant difference between anxiety levels a t  baseline 
and at  15 min. Comparing baseline to anxiety levels 
prior to induction, there was a significant difference 
in the fentanyl and sufentanil groups using the Bonfer- 
roni correction. 
Between groups at  baseline there was a significant 
difference between mean anxiety level of the meperi- 
dine and fentanyl groups. At the 15-min measurement 
the morphine, meperidine, fentanyl and sufentanil 
groups had significantly lower mean anxiety levels 
than the placebo group. Just prior to induction only 
the sufentanil group had a mean anxiety level signifi- 
cantly lower than placebo. 
Similarly, 15 min after premedication, grades of 
sedation were significantly higher (indicating more 
sedation) in all active medication groups compared to 
the placebo group. However, just before induction of 
anaesthesia, only the fentanyl and sufentanil groups 
were significantly different from placebo in this respect 
(Fig. 1). The anesthesiologists’ overall evaluation of 
premedication favoured sufentanil (70% good to ex- 
cellent) compared to morphine (45y0), meperidine 
(45%), fentanyl (40%) and the placebo (20%) (Table 
4). In  this respect, only sufentanil was significantly 
different (statistically) to placebo. 
Satisfactory induction of anaesthesia was defined as 
a case that required no additional thiamylal. Satisfac- 
tory maintenance was a case that did not require any 
additional narcotic (fentanyl) to maintain anaesthesia. 
Patients receiving sufentanil premedication had satis- 
factory induction in 100% of the cases and satisfactory 
maintenance of anaesthesia in 95% of the cases (Table 
5). This table thus in effect shows the number of 
patients who required no additional thiamylal during 
induction and no additional fentanyl during mainten- 
ance. Only the data on sufentanil were significantly 
different from the placebo results both during induc- 
tion and maintenance. 
Table 3 
Anxiety scores and premedication (mean s.d.) (percent reduction from baseline in parenthesis). 
Premedicant n Baseline 15 min Prior to induction 
Morphine 20 50.7 f 26.91 * + 28.3 & 24.62 (-45%) 39.6 f 29.51 ( -  22%) 
Meperidine 20 t44.7 f 24.57 *+21.3+ 19.46 (-52%) 30.9 f 29.29 ( -  30%) 
Sufentanil 20 52.0 f 26.3 *+27.1 k23.91 (-48%) **29.6 f 28.68* (-43%) 
Placebo 20 51.9 f 27.02 43.5 & 29.20 ( -  16%) 48.7 f 26.89 ( -  6%) 
Fentanyl 20 t65.1 f 26.32 * + 32.7 f 19.23 ( -  50%) 45.5 f 27.88* ( -  30%) 
t ANOVA P <  0.05 between meperidine and fentanyl. 
+ ANOVA P<0.05 when compared to placebo. 
**  ANOVA P<0.05 when compared to placebo. 
* P50.05 Pairwise t-test with Bonferroni correction when compared to baseline. 
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Table 4 
Anesthesiologists’ overall evaluation of premedication (%). 
Premedicant Excellent/good Fair/poor 
Morphine 45 55 
Meperidine 45 55 
Fentanyl 40 60 
Sufentanil * 70 *30 
Placebo 20 80 
* Sufentanil significantly different from placebo (chi-square test). 
The Aldrete recovery room scores on arrival in the 
recovery room were similar in all groups (range 8.5 
0.8 to 8.7 1.3) and were statistically insignificant. 
The recovery times (time to complete orientation, time 
to ambulation and time to discharge) are shown in 
Table 6. These times were not significantly different 
among the various groups (ANOVA). 
The frequency of side effects is shown in Table 7. 
There was a trend to greater nausea and vomiting in 
the morphine and meperidine groups (25 and 20%, 
respectively), but the incidence in the sufentanil group 
was the same as in the placebo group (10%). The 
fentanyl group had a 15% incidence of nausea and 
vomiting. Differences between the groups regarding 
the incidence of nausea and vomiting, however, did 
not reach statistical significance. The frequency of ex- 
cessive drowsiness in the recovery room was similar 
among the groups and was not statistically different. 
The need for intravenous and oral analgesics in the 
recovery room was also not different among the 
groups. 
Patients were telephoned at home 24 and 48 h after 
the operation and were asked, “When did you feel 
normal?” Between 80 and 95% of patients in various 
groups said they felt normal by the second postopera- 
tive day (the day after the operation). There was 
no significant difference among the groups regarding 
recovery time, and results are not shown. None of the 
patients suffered from other significant side effects, 
such as protracted nausea/vomiting, dizziness, drowsi- 
ness and muscle pain. 
Table 5 
Quality of anesthesia (%) after premedications. 
Premedicant Satisfactory induction Satisfactory maintenance 
Morphine 95 * 80 
Fentanyl 95* 85 
Sufentanil 
Placebo 65 65 
* Placebo was significantly different from fentanyl, sufentanil and 
morphine (chi-square test), 
t Placebo significantly different than sufentanil (chi-square test). 
Meperidine 85 75 
loo* 95 t 
Table 6 
Recovery time (in min) for prernedication patient groups (mean 
s.d.). 
Premedicant Orientation Ambulation Discharge 
Morphine 21.4 f 6.63 148.4 f 49.33 210.3 f 65.84 
Meperidine 19.2 f 6.54 135.2 k 30.02 187.0 f 50.87 
Fentanyl 19.9 f 7.41 145.8 f 51.73 187.9 i 67.73 
Sufentanyl 19.7 f 8.19 134.2 f 44.05 181.5 f 62.01 
Placebo 20.2 f 7.69 156.0 f 54.04 200.0 69.12 
~ ~ ~~ 
No significant difference among groups (ANOVA). 
Arterial pressures, heart rates and respiratory rates 
following premedication, during induction and main- 
tenance of anaesthesia and also during the recovery 
room period were remarkably stable in all groups, 
and are not shown. Arterial pressure and heart rate 
increased transiently and significantly in all groups 
following endotracheal intubation. 
DISCUSSION 
There are a number of papers in the literature which 
suggest that judicious use of premedicants for out- 
patient surgical patients does not delay recovery time 
(3, 4). However, the common benzodiazepine, di- 
azepam, is usually avoided for outpatients because of 
its long elimination half-life and its potential for pain 
on injection, tissue damage and thrombophlebitis. Lo- 
razepam is too long acting an agent to be useful in 
outpatient anaesthesia. The new water-soluble, short- 
acting midazolam is a good anxiolytic and not painful 
on injection, and is thus suitable for outpatient use 
(5). Of the narcotics we compared with a placebo as 
intravenous premedicants, the two short-acting 
agents, fentanyl and sufentanil, especially sufentanil, 
stood out as the most promising for the purpose. Sufen- 
tanil not only reduced preoperative patient anxiety 
but also provided smoother induction and mainten- 
ance, without increasing postoperative side effects such 
as nausea, and without delaying discharge time. 
The equianalgesic doses of narcotics, especially fen- 
tanyl versus sufentanil, have been a matter on which 
there are conflicting views (6, 7 ) .  Sufentanil has been 
Table 7 
Side effects in the recovery room (yo). 
Premedicant Nausea/vomiting Drowsiness Excessive pain 
Morphine 25 15 45 
Meperidine 20 20 45 
Fentanyl 15 15 45 
Placebo 10 15 45 
Sufentanil 10 15 40 
No significant difference between groups (chi-square tests). 
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claimed to be five times as potent as fentanyl, although 
recent studies have suggested even higher potency. 
On  the other hand, equipotency of the narcotics as 
antianxiety agents is unknown. Regarding equipotent 
doses of morphine, meperidine and fentanyl, Mar- 
shall & Wollman (8) stated in a highly respected phar- 
macology textbook that “intravenous doses of 1 to 2 
mg of morphine, 10 to 25 mg of meperidine and 0.05 
to 0.1 rng of fentanyl are approximately equipotent”. 
The doses we used were within these recommen- 
dations. 
Many anaesthesiologists believe that morphine and 
meperidine premedication often cause euphoria, 
which helps in decreasing patient anxiety, We did not 
see any sign of euphoria with any of these agents in 
our study. Not only were these two long-acting agents 
less effective in reducing preoperative anxiety, but 
their contribution to the improved quality of induction 
and maintenance was also less clearcut. Furthermore, 
there was a trend towards a higher incidence of nausea 
and vomiting in patients who received morphine and 
meperidine, compared to those who received the pla- 
cebo, although with the number of cases in our study 
this difference did not reach the level of statistical 
significance. Conner et al. (9) compared morphine 
and meperidine (in much higher doses than ours) as 
intravenous premedicants, and reported findings very 
similar to ours. They found neither meperidine nor 
morphine to be particularly good surgical preme- 
dicants. Neither caused significant euphoria or relief 
from anxiety, and the incidence of nausea and vomit- 
ing after premedication was high. 
The incidence of postoperative nausea and vomiting 
in all groups was low in our study. Previous studies in 
the same patient population (young females undergo- 
ing a laparoscopic procedure), with a very similar 
anaesthetic technique, showed a very high incidence 
(50-600/,) of postoperative nausea and vomiting (10). 
In the present study we used droperidol 0.625 mg 
i.v. as a prophylactic antiernetic agent at the time of 
induction of anaesthesia. We believe that pretreatment 
with droperidol (1 l ) ,  as well as routine decompression 
of the stomach during operation, were the reasons for 
the lower incidence and lower severity of nausea and 
vomiting. 
About 50% of the patients receiving intravenous 
narcotic premedication, including sufentanil, 
complained of transient light-headedness immediately 
after the injection. Although this side effect lasted only 
1 or 2 min, it might be considered a drawback of 
intravenous premedication. We did not notice any 
obvious rigidity, excessive tachycardia or hypotension 
after the premedicants. The high incidence of dis- 
comfort during i.v. injection of morphine and meperi- 
dine was surprising, but these discomforts were minor 
in nature and were obtained only on direct questioning 
immediately after injection. 
Dispensing the small dose of sufentanil 10-20 pg 
in the commercially available concentration would 
appear cumbersome and even dangerous (because of 
the possibility of a mistake in delivering small doses); 
to avoid these problems we recommend routine di- 
lution of sufentanil a t  5-10 pg. ml-’ to be used only 
in the preoperative waiting room (for outpatient or 
inpatients) and not on the inpatient floor. 
With the introduction of the water-soluble, short- 
acting benzodiazepine, midazolam (Roche), the need 
for an intravenous narcotic premedication might ap- 
pear to have receded. However, midazolam does not 
possess any analgesic property; thus, in cases where a 
potent analgesic is a necessity during the operation, 
sufentanil premedication might still have an important 
place in outpatient anesthesia. Besides, the profound 
anterograde amnesic effects of midazolam (5) may 
be considered as a disadvantage in some outpatient 
surgical patients. 
We conclude from our study that if an outpatient 
needs a pharmacological premedication, an intra- 
venous, short-acting narcotic, should be considered as 
an alternative. Sufentanil 0.15 pg. kg-’ given intra- 
venously is superior to a placebo and to other common 
narcotics as a premedicant. 
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